CD39 and CD73 as promising therapeutic targets : what could be the limitations?

View/Open
Date
2021
Author
Type
URI
http://hdl.handle.net/10183/221805
Subject
In
Frontiers in pharmacology. Lausanne. Vol. 12 (Mar. 2021), 633603, 5 p.
Source
Foreign
Collections
 
   

This item is licensed under a Creative Commons License